Expression optimization of a cell membrane-penetrating human papillomavirus type 16 therapeutic vaccine candidate in Nicotiana benthamiana-Reference-Cited by-同舟云学术

Expression optimization of a cell membrane-penetrating human papillomavirus type 16 therapeutic vaccine candidate in Nicotiana benthamiana

Published:2017-08-11 Issue:8 Volume:12 Page:e0183177
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yanez Romana J. R.,Lamprecht Renate,Granadillo Milaid,Weber Brandon,Torrens Isis,Rybicki Edward P.,Hitzeroth Inga I.^ORCID

Funder

Poliomyelitis Research Foundation

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference62 articles.

1. Centers for disease control and prevention. CDC—Global Cancer Statistics. Int Cancer Control 2012. http://www.cdc.gov/cancer/international/statistics.htm (accessed 18 August 2016).

2. The cancer burden attributable to biologic agents;D Schottenfeld;Ann Epidemiol,2015

3. WHO | Human papillomavirus (HPV) and cervical cancer,2016

4. Human papillomavirus vaccines in plants;C Giorgi;Expert Rev Vaccines,2010

5. Papillomaviruses and cancer: from basic studies to clinical application;H Zur Hausen;Nat Rev Cancer,2002

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and Opportunities in the Process Development of Chimeric Vaccines;Vaccines;2023-12-08

2. Targeting Specific Barriers;CPP, Cell-Penetrating Peptides;2023

3. Therapeutic Potential of CPPs;CPP, Cell-Penetrating Peptides;2023

4. Introduction;CPP, Cell-Penetrating Peptides;2023

5. Harnessing the Potential of Plant Expression System towards the Production of Vaccines for the Prevention of Human Papillomavirus and Cervical Cancer;Vaccines;2022-12-01